Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Tata Mumbai Marathon 2026: Delhi Capitals Owner Parth Jindal Completes Half-Marathon In Under 2...
Tata Mumbai Marathon 2026: Delhi Capitals Owner Parth Jindal Completes Half-Marathon In Under 2...
Q3 Earnings, Global Cues To Shape Market Direction This Week, Banking & Heavyweights In Focus Say...
Q3 Earnings, Global Cues To Shape Market Direction This Week, Banking & Heavyweights In Focus Say...
Budget 2026: How Much Tax Relief For The Common Man, What May Get Cheaper Or Costlier- Key Takeaways...
Budget 2026: How Much Tax Relief For The Common Man, What May Get Cheaper Or Costlier- Key Takeaways...
Maruti Suzuki To Invest Rs 35,000 Crore In New Gujarat Plant, 12,000 Jobs Likely Near Ahmedabad
Maruti Suzuki To Invest Rs 35,000 Crore In New Gujarat Plant, 12,000 Jobs Likely Near Ahmedabad
Big Promises In Rare Earths, Tough Ground Reality: Why Pakistan’s US Mineral Deal Faces Major...
Big Promises In Rare Earths, Tough Ground Reality: Why Pakistan’s US Mineral Deal Faces Major...